当前位置:首页 - 行情中心 - 澳华内镜(688212) - 财务分析 - 利润表

澳华内镜

(688212)

  

流通市值:62.71亿  总市值:62.71亿
流通股本:1.35亿   总股本:1.35亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入123,727,829.72749,549,531.34500,553,520.06353,524,229.81
营业收入123,727,829.72749,549,531.34500,553,520.06353,524,229.81
二、营业总成本166,577,607.61767,016,745.83504,921,469.56371,843,932.97
营业成本41,624,998.3238,927,723.27153,910,636.66100,909,672.24
税金及附加1,223,340.765,674,035.314,017,763.372,685,063.23
销售费用52,341,423.37250,203,776.88159,507,236.16122,623,118.18
管理费用29,968,260.49108,532,136.5674,775,177.358,682,045.76
研发费用41,759,818.78163,598,045.33113,108,128.2787,336,827.97
财务费用-340,234.0981,028.48-397,472.2-392,794.41
其中:利息费用1,009,320.521,936,192.11945,037.45332,423.93
其中:利息收入629,434.092,450,422.791,810,216.01776,653.11
加:公允价值变动收益-3,885,207.624,604,982.933,930,867.61
加:投资收益-190,749.556,355,758.843,952,895.622,612,673.66
资产处置收益-5,373.88260,425.7155,585.46150,881.07
资产减值损失(新)-3,642,234.39-23,981,611.25-4,201,136.28-2,785,445.75
信用减值损失(新)-2,335,768.29-13,663,274.97-9,957,624.64-7,564,626.39
其他收益11,336,316.2351,654,441.4940,381,370.0919,877,800.17
营业利润平衡项目0000
四、营业利润-37,687,587.777,043,732.9430,568,123.68-2,097,552.79
加:营业外收入2,344.26212,089.224,324.074,112.59
减:营业外支出183.83829,496.81484,230.51294,859.69
利润总额平衡项目0000
五、利润总额-37,685,427.346,426,325.3530,088,217.24-2,388,299.89
减:所得税费用-8,879,820.56-13,897,043.77-6,870,136.43-7,960,328.61
六、净利润-28,805,606.7820,323,369.1236,958,353.675,572,028.72
持续经营净利润-28,805,606.7820,323,369.1236,958,353.675,572,028.72
归属于母公司股东的净利润-28,791,459.6821,012,248.8837,303,031.495,661,627.44
少数股东损益-14,147.1-688,879.76-344,677.82-89,598.72
(一)基本每股收益-0.210.160.280.04
(二)稀释每股收益-0.210.160.280.04
八、其他综合收益1,956,247.66-2,386,147.77-229,909.45-1,409,777.16
归属于母公司股东的其他综合收益1,956,247.66-2,386,147.77-229,909.45-1,409,777.16
九、综合收益总额-26,849,359.1217,937,221.3536,728,444.224,162,251.56
归属于母公司股东的综合收益总额-26,835,212.0218,626,101.1137,073,122.044,251,850.28
归属于少数股东的综合收益总额-14,147.1-688,879.76-344,677.82-89,598.72
公告日期2025-04-182025-04-102024-10-252024-08-23
审计意见(境内)标准无保留意见
TOP↑